Skip to main content

Find Clinical Trials

Home
Conditions
Refractory Marginal Zone Lymphoma

Clinical trial condition

Refractory Marginal Zone Lymphoma

Explore clinical trials studying Refractory Marginal Zone Lymphoma. Study availability and eligibility vary by location and protocol.

13 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Refractory Marginal Zone Lymphoma trial results

Active, Not Recruiting

Pevonedistat and Ibrutinib in Treating Participants With Relapsed or Refractory CLL or Non-Hodgkin Lymphoma

NCT03479268

Conditions: B-Cell Prolymphocytic Leukemia, Chronic Disease, Disease Attributes, +40 more
Locations: City of Hope Medical Center Duarte, California, United States

Roswell Park Comprehensive Cancer Center Buffalo, New York, United States

View Trial Details

Active, Not Recruiting

ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma

NCT05025800

Conditions: Aggressive B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage III Grade 2 Follicular Lymphoma, Ann Arbor Stage III Grade 3 Follicular Lymphoma, +31 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

An Early Phase Study of Venetoclax, Lenalidomide, and Rituximab/Hyaluronidase in Slow-Growing Lymphomas That Have Come Back After Treatment or Have Not Responded to Treatment

NCT04447716

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +17 more
Locations: Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details